CITADEL ADVISORS LLC

Position in BBNX — Beta Bionics, Inc.

CIK 1423053 MIAMI, FL

Back to BBNX Full portfolio

Position in BBNX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

-$522,462 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Common Shares in BBNX Over Time

Shares Held

Position Value (USD)

Derivatives in BBNX

reported options exposure · as of Jun 30, 2026

CallValue

$633,068

CallShares

40,400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $3,441,341,341 across 94 Medical Devices names.

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	8,597,227	$780,112,377
2	MDT	Medtronic plc	5,373,877	$420,398,397
3	EW	Edwards Lifesciences Corp	3,997,925	$361,652,295
4	ZBH	Zimmer Biomet Holdings, Inc.	3,477,472	$299,375,563
5	BSX	Boston Scientific Corp	4,987,748	$212,877,084
6	GKOS	GLAUKOS Corp	1,390,017	$194,268,775
7	GEHC	GE HealthCare Technologies Inc.	2,367,032	$151,513,717
8	PEN	Penumbra Inc	448,763	$141,696,917

All Filings in BBNX

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$633,068	40,400	+59.7%	Call	Defined	2026-08-14
2026-03-31	$253,506	25,300	+145.6%	Call	Defined	2026-05-15
2026-03-31	$522,462	52,142	-83.8%	Shares	Defined	2026-05-15
2025-12-31	$313,841	10,300	—	Call	Defined	2026-02-17
2025-12-31	$9,777,213	320,880	-40.6%	Shares	Defined	2026-02-17
2025-06-30	$7,861,861	539,963	-42.9%	Shares	Defined	2025-08-14
2025-03-31	$11,583,323	946,350	—	Shares	Defined	2025-05-15
No filing history on record for this holder in this stock.